APO Research
Talk to an analyst

APO RESEARCH · REPORT

Biopharmaceuticals Contract Manufacturing Service

Compare research editions
View pricing & licenses

Selected research

Industry Research

Biopharmaceuticals Contract Manufacturing Service Industry Research Report 2026

31 December 2025133 pages

Choose your research edition.

Industry ResearchBiopharmaceuticals Contract Manufacturing Service Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Biopharmaceuticals Contract Manufacturing Service Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Biopharmaceuticals Contract Manufacturing Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Biopharmaceuticals Contract Manufacturing Service Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Biopharmaceuticals Contract Manufacturing Service Market Analysis and Forecast 2026-2032206 pages · $4,950 USD

Market perspective

The global Biopharmaceuticals Contract Manufacturing Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

North America: the Biopharmaceuticals Contract Manufacturing Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Biopharmaceuticals Contract Manufacturing Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Biopharmaceuticals Contract Manufacturing Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Biopharmaceuticals Contract Manufacturing Service include WuXi Biologics, Takeda, Sanofi, Johnson & Johnson, Merck, Roche, Lonza Group, Pfizer and GlaxoSmithKline, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

Read the full market overview

This report quantifies the global Biopharmaceuticals Contract Manufacturing Service market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Biopharmaceuticals Contract Manufacturing Service.

Key Companies & Market Share Insights

This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Biopharmaceuticals Contract Manufacturing Service Market by Company

WuXi Biologics

Takeda

Sanofi

Johnson & Johnson

Merck

Roche

Lonza Group

Pfizer

GlaxoSmithKline

AbbVie

Samsung BioLogics

Rentschler Biotechnologie

ProBioGen

Novo Medi Sciences

JRS Pharma

Galentic Pharma

FUJIFILM Diosynth Biotechnologies

Boehringer Ingelheim

AGC Biologics

Biopharmaceuticals Contract Manufacturing Service Segment by Type

Packaging

Process Development

Manufacturing

Biopharmaceuticals Contract Manufacturing Service Segment by Application

Vaccines

Peptides and Protein

Biosimilars

Antibodies

Others

Biopharmaceuticals Contract Manufacturing Service Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Spain

Russia

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Saudi Arabia

Israel

United Arab Emirates

Turkey

Iran

Egypt

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biopharmaceuticals Contract Manufacturing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biopharmaceuticals Contract Manufacturing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biopharmaceuticals Contract Manufacturing Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 6: Detailed analysis of Biopharmaceuticals Contract Manufacturing Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 13: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Biopharmaceuticals Contract Manufacturing Service Market Size by Type (2021-2026) & (US$ Million) Table 6. Global Biopharmaceuticals Contract Manufacturing Service Revenue Market Share by Type (2021-2026) Table 7. Global Biopharmaceuticals Contract Manufacturing Service Forecasted Market Size by Type (2027-2032) & (US$ Million) Table 8. Global Biopharmaceuticals Contract Manufacturing Service Revenue Market Share by Type (2027-2032) Table 9. Global Biopharmaceuticals Contract Manufacturing Service Market Size by Application (2021-2026) & (US$ Million) Table 10. Global Biopharmaceuticals Contract Manufacturing Service Revenue Market Share by Application (2021-2026) Table 11. Global Biopharmaceuticals Contract Manufacturing Service Forecasted Market Size by Application (2027-2032) & (US$ Million) Table 12. Global Biopharmaceuticals Contract Manufacturing Service Revenue Market Share by Application (2027-2032) Table 13. Global Biopharmaceuticals Contract Manufacturing Service Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Biopharmaceuticals Contract Manufacturing Service Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Biopharmaceuticals Contract Manufacturing Service Market Share by Region (2021-2026) Table 16. Global Biopharmaceuticals Contract Manufacturing Service Forecasted Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Biopharmaceuticals Contract Manufacturing Service Market Share by Region (2027-2032) Table 18. Biopharmaceuticals Contract Manufacturing Service Industry Trends Table 19. Biopharmaceuticals Contract Manufacturing Service Industry Drivers Table 20. Biopharmaceuticals Contract Manufacturing Service Industry Opportunities and Challenges Table 21. Biopharmaceuticals Contract Manufacturing Service Market Restraints Table 22. Global Top Biopharmaceuticals Contract Manufacturing Service Players by Revenue (US$ Million) & (2021-2026) Table 23. Global Biopharmaceuticals Contract Manufacturing Service Revenue Market Share by Players (2021-2026) Table 24. Global Biopharmaceuticals Contract Manufacturing Service Industry Players Ranking, 2024 VS 2025 VS 2026 Table 25. Global Key Players of Biopharmaceuticals Contract Manufacturing Service, Headquarters and Area Served Table 26. Global Biopharmaceuticals Contract Manufacturing Service Players, Product Type & Application Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global Biopharmaceuticals Contract Manufacturing Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Players Mergers & Acquisitions, Expansion Plans Table 30. North America Biopharmaceuticals Contract Manufacturing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 31. North America Biopharmaceuticals Contract Manufacturing Service Market Size by Country (2021-2026) & (US$ Million) Table 32. North America Biopharmaceuticals Contract Manufacturing Service Market Size by Country (2027-2032) & (US$ Million) Table 33. Europe Biopharmaceuticals Contract Manufacturing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Europe Biopharmaceuticals Contract Manufacturing Service Market Size by Country (2021-2026) & (US$ Million) Table 35. Europe Biopharmaceuticals Contract Manufacturing Service Market Size by Country (2027-2032) & (US$ Million) Table 36. Asia Pacific Biopharmaceuticals Contract Manufacturing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Asia Pacific Biopharmaceuticals Contract Manufacturing Service Market Size by Region (2021-2026) & (US$ Million) Table 38. Asia Pacific Biopharmaceuticals Contract Manufacturing Service Market Size by Country (2027-2032) & (US$ Million) Table 39. South America Biopharmaceuticals Contract Manufacturing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 40. South America Biopharmaceuticals Contract Manufacturing Service Market Size by Country (2021-2026) & (US$ Million) Table 41. South America Biopharmaceuticals Contract Manufacturing Service Market Size by Country (2027-2032) & (US$ Million) Table 42. Middle East & Africa Biopharmaceuticals Contract Manufacturing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 43. Middle East & Africa Biopharmaceuticals Contract Manufacturing Service Market Size by Country (2021-2026) & (US$ Million) Table 44. Middle East & Africa Biopharmaceuticals Contract Manufacturing Service Market Size by Country (2027-2032) & (US$ Million) Table 45. WuXi Biologics Company Information Table 46. WuXi Biologics Business Overview Table 47. WuXi Biologics Revenue in Biopharmaceuticals Contract Manufacturing Service Business (2021-2026) & (US$ Million) Table 48. WuXi Biologics Biopharmaceuticals Contract Manufacturing Service Product Portfolio Table 49. WuXi Biologics Recent Developments Table 50. Takeda Company Information Table 51. Takeda Business Overview Table 52. Takeda Revenue in Biopharmaceuticals Contract Manufacturing Service Business (2021-2026) & (US$ Million) Table 53. Takeda Biopharmaceuticals Contract Manufacturing Service Product Portfolio Table 54. Takeda Recent Developments Table 55. Sanofi Company Information Table 56. Sanofi Business Overview Table 57. Sanofi Revenue in Biopharmaceuticals Contract Manufacturing Service Business (2021-2026) & (US$ Million) Table 58. Sanofi Biopharmaceuticals Contract Manufacturing Service Product Portfolio Table 59. Sanofi Recent Developments Table 60. Johnson & Johnson Company Information Table 61. Johnson & Johnson Business Overview Table 62. Johnson & Johnson Revenue in Biopharmaceuticals Contract Manufacturing Service Business (2021-2026) & (US$ Million) Table 63. Johnson & Johnson Biopharmaceuticals Contract Manufacturing Service Product Portfolio Table 64. Johnson & Johnson Recent Developments Table 65. Merck Company Information Table 66. Merck Business Overview Table 67. Merck Revenue in Biopharmaceuticals Contract Manufacturing Service Business (2021-2026) & (US$ Million) Table 68. Merck Biopharmaceuticals Contract Manufacturing Service Product Portfolio Table 69. Merck Recent Developments Table 70. Roche Company Information Table 71. Roche Business Overview Table 72. Roche Revenue in Biopharmaceuticals Contract Manufacturing Service Business (2021-2026) & (US$ Million) Table 73. Roche Biopharmaceuticals Contract Manufacturing Service Product Portfolio Table 74. Roche Recent Developments Table 75. Lonza Group Company Information Table 76. Lonza Group Business Overview Table 77. Lonza Group Revenue in Biopharmaceuticals Contract Manufacturing Service Business (2021-2026) & (US$ Million) Table 78. Lonza Group Biopharmaceuticals Contract Manufacturing Service Product Portfolio Table 79. Lonza Group Recent Developments Table 80. Pfizer Company Information Table 81. Pfizer Business Overview Table 82. Pfizer Revenue in Biopharmaceuticals Contract Manufacturing Service Business (2021-2026) & (US$ Million) Table 83. Pfizer Biopharmaceuticals Contract Manufacturing Service Product Portfolio Table 84. Pfizer Recent Developments Table 85. GlaxoSmithKline Company Information Table 86. GlaxoSmithKline Business Overview Table 87. GlaxoSmithKline Revenue in Biopharmaceuticals Contract Manufacturing Service Business (2021-2026) & (US$ Million) Table 88. GlaxoSmithKline Biopharmaceuticals Contract Manufacturing Service Product Portfolio Table 89. GlaxoSmithKline Recent Developments Table 90. AbbVie Company Information Table 91. AbbVie Business Overview Table 92. AbbVie Revenue in Biopharmaceuticals Contract Manufacturing Service Business (2021-2026) & (US$ Million) Table 93. AbbVie Biopharmaceuticals Contract Manufacturing Service Product Portfolio Table 94. AbbVie Recent Developments Table 95. Samsung BioLogics Company Information Table 96. Samsung BioLogics Business Overview Table 97. Samsung BioLogics Revenue in Biopharmaceuticals Contract Manufacturing Service Business (2021-2026) & (US$ Million) Table 98. Samsung BioLogics Biopharmaceuticals Contract Manufacturing Service Product Portfolio Table 99. Samsung BioLogics Recent Developments Table 100. Rentschler Biotechnologie Company Information Table 101. Rentschler Biotechnologie Business Overview Table 102. Rentschler Biotechnologie Revenue in Biopharmaceuticals Contract Manufacturing Service Business (2021-2026) & (US$ Million) Table 103. Rentschler Biotechnologie Biopharmaceuticals Contract Manufacturing Service Product Portfolio Table 104. Rentschler Biotechnologie Recent Developments Table 105. ProBioGen Company Information Table 106. ProBioGen Business Overview Table 107. ProBioGen Revenue in Biopharmaceuticals Contract Manufacturing Service Business (2021-2026) & (US$ Million) Table 108. ProBioGen Biopharmaceuticals Contract Manufacturing Service Product Portfolio Table 109. ProBioGen Recent Developments Table 110. Novo Medi Sciences Company Information Table 111. Novo Medi Sciences Business Overview Table 112. Novo Medi Sciences Revenue in Biopharmaceuticals Contract Manufacturing Service Business (2021-2026) & (US$ Million) Table 113. Novo Medi Sciences Biopharmaceuticals Contract Manufacturing Service Product Portfolio Table 114. Novo Medi Sciences Recent Developments Table 115. JRS Pharma Company Information Table 116. JRS Pharma Business Overview Table 117. JRS Pharma Revenue in Biopharmaceuticals Contract Manufacturing Service Business (2021-2026) & (US$ Million) Table 118. JRS Pharma Biopharmaceuticals Contract Manufacturing Service Product Portfolio Table 119. JRS Pharma Recent Developments Table 120. Galentic Pharma Company Information Table 121. Galentic Pharma Business Overview Table 122. Galentic Pharma Revenue in Biopharmaceuticals Contract Manufacturing Service Business (2021-2026) & (US$ Million) Table 123. Galentic Pharma Biopharmaceuticals Contract Manufacturing Service Product Portfolio Table 124. Galentic Pharma Recent Developments Table 125. FUJIFILM Diosynth Biotechnologies Company Information Table 126. FUJIFILM Diosynth Biotechnologies Business Overview Table 127. FUJIFILM Diosynth Biotechnologies Revenue in Biopharmaceuticals Contract Manufacturing Service Business (2021-2026) & (US$ Million) Table 128. FUJIFILM Diosynth Biotechnologies Biopharmaceuticals Contract Manufacturing Service Product Portfolio Table 129. FUJIFILM Diosynth Biotechnologies Recent Developments Table 130. Boehringer Ingelheim Company Information Table 131. Boehringer Ingelheim Business Overview Table 132. Boehringer Ingelheim Revenue in Biopharmaceuticals Contract Manufacturing Service Business (2021-2026) & (US$ Million) Table 133. Boehringer Ingelheim Biopharmaceuticals Contract Manufacturing Service Product Portfolio Table 134. Boehringer Ingelheim Recent Developments Table 135. AGC Biologics Company Information Table 136. AGC Biologics Business Overview Table 137. AGC Biologics Revenue in Biopharmaceuticals Contract Manufacturing Service Business (2021-2026) & (US$ Million) Table 138. AGC Biologics Biopharmaceuticals Contract Manufacturing Service Product Portfolio Table 139. AGC Biologics Recent Developments Table 140. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Biopharmaceuticals Contract Manufacturing Service Product Image Figure 5. Global Biopharmaceuticals Contract Manufacturing Service Market Size Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 6. Global Biopharmaceuticals Contract Manufacturing Service Market Share by Type: 2025 VS 2032 Figure 7. Packaging Product Figure 8. Process Development Product Figure 9. Manufacturing Product Figure 10. Global Biopharmaceuticals Contract Manufacturing Service Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Biopharmaceuticals Contract Manufacturing Service Market Share by Application: 2025 VS 2032 Figure 12. Vaccines Product Figure 13. Peptides and Protein Product Figure 14. Biosimilars Product Figure 15. Antibodies Product Figure 16. Others Product Figure 17. Global Biopharmaceuticals Contract Manufacturing Service Market Size (US$ Million), Year-over-Year: 2021-2032 Figure 18. Global Biopharmaceuticals Contract Manufacturing Service Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 19. Global Biopharmaceuticals Contract Manufacturing Service Market Share by Region: 2025 VS 2032 Figure 20. Global Biopharmaceuticals Contract Manufacturing Service Market Share by Players in 2025 Figure 21. Global Biopharmaceuticals Contract Manufacturing Service Manufacturers Established Date Figure 22. Global Top 5 and 10 Biopharmaceuticals Contract Manufacturing Service Players Market Share by Revenue in 2025 Figure 23. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 24. North America Biopharmaceuticals Contract Manufacturing Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Biopharmaceuticals Contract Manufacturing Service Market Share by Country (2021-2032) Figure 26. United States Biopharmaceuticals Contract Manufacturing Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Canada Biopharmaceuticals Contract Manufacturing Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 28. Mexico Biopharmaceuticals Contract Manufacturing Service Market Share by Country (2021-2032) Figure 29. Europe Biopharmaceuticals Contract Manufacturing Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Biopharmaceuticals Contract Manufacturing Service Market Share by Country (2021-2032) Figure 31. Germany Biopharmaceuticals Contract Manufacturing Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 32. France Biopharmaceuticals Contract Manufacturing Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. U.K. Biopharmaceuticals Contract Manufacturing Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 34. Italy Biopharmaceuticals Contract Manufacturing Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Spain Biopharmaceuticals Contract Manufacturing Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 36. Russia Biopharmaceuticals Contract Manufacturing Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Netherlands Biopharmaceuticals Contract Manufacturing Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 38. Nordic Countries Biopharmaceuticals Contract Manufacturing Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 39. Asia-Pacific Biopharmaceuticals Contract Manufacturing Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 40. Asia-Pacific Biopharmaceuticals Contract Manufacturing Service Market Share by Country (2021-2032) Figure 41. China Biopharmaceuticals Contract Manufacturing Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 42. Japan Biopharmaceuticals Contract Manufacturing Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 43. South Korea Biopharmaceuticals Contract Manufacturing Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 44. India Biopharmaceuticals Contract Manufacturing Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 45. India Biopharmaceuticals Contract Manufacturing Service Market Share by Country (2021-2032) Figure 46. Australia Biopharmaceuticals Contract Manufacturing Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 47. China Taiwan Biopharmaceuticals Contract Manufacturing Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 48. Southeast Asia Biopharmaceuticals Contract Manufacturing Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 49. South America Biopharmaceuticals Contract Manufacturing Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 50. South America Biopharmaceuticals Contract Manufacturing Service Market Share by Country (2021-2032) Figure 51. Brazil Biopharmaceuticals Contract Manufacturing Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 52. Argentina Biopharmaceuticals Contract Manufacturing Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 53. Chile Biopharmaceuticals Contract Manufacturing Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 54. Colombia Biopharmaceuticals Contract Manufacturing Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 55. Peru Biopharmaceuticals Contract Manufacturing Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 56. WuXi Biologics Revenue Growth Rate in Biopharmaceuticals Contract Manufacturing Service Business (2021-2026) Figure 57. Takeda Revenue Growth Rate in Biopharmaceuticals Contract Manufacturing Service Business (2021-2026) Figure 58. Sanofi Revenue Growth Rate in Biopharmaceuticals Contract Manufacturing Service Business (2021-2026) Figure 59. Johnson & Johnson Revenue Growth Rate in Biopharmaceuticals Contract Manufacturing Service Business (2021-2026) Figure 60. Merck Revenue Growth Rate in Biopharmaceuticals Contract Manufacturing Service Business (2021-2026) Figure 61. Roche Revenue Growth Rate in Biopharmaceuticals Contract Manufacturing Service Business (2021-2026) Figure 62. Lonza Group Revenue Growth Rate in Biopharmaceuticals Contract Manufacturing Service Business (2021-2026) Figure 63. Pfizer Revenue Growth Rate in Biopharmaceuticals Contract Manufacturing Service Business (2021-2026) Figure 64. GlaxoSmithKline Revenue Growth Rate in Biopharmaceuticals Contract Manufacturing Service Business (2021-2026) Figure 65. AbbVie Revenue Growth Rate in Biopharmaceuticals Contract Manufacturing Service Business (2021-2026) Figure 66. Samsung BioLogics Revenue Growth Rate in Biopharmaceuticals Contract Manufacturing Service Business (2021-2026) Figure 67. Rentschler Biotechnologie Revenue Growth Rate in Biopharmaceuticals Contract Manufacturing Service Business (2021-2026) Figure 68. ProBioGen Revenue Growth Rate in Biopharmaceuticals Contract Manufacturing Service Business (2021-2026) Figure 69. Novo Medi Sciences Revenue Growth Rate in Biopharmaceuticals Contract Manufacturing Service Business (2021-2026) Figure 70. JRS Pharma Revenue Growth Rate in Biopharmaceuticals Contract Manufacturing Service Business (2021-2026) Figure 71. Galentic Pharma Revenue Growth Rate in Biopharmaceuticals Contract Manufacturing Service Business (2021-2026) Figure 72. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Biopharmaceuticals Contract Manufacturing Service Business (2021-2026) Figure 73. Boehringer Ingelheim Revenue Growth Rate in Biopharmaceuticals Contract Manufacturing Service Business (2021-2026) Figure 74. AGC Biologics Revenue Growth Rate in Biopharmaceuticals Contract Manufacturing Service Business (2021-2026)

Scope & coverage.

Types
  • Packaging
  • Process Development
  • Manufacturing
Applications
  • Vaccines
  • Peptides and Protein
  • Biosimilars
  • Antibodies
  • Others
Companies covered
  • WuXi Biologics
  • Takeda
  • Sanofi
  • Johnson & Johnson
  • Merck
  • Roche
  • Lonza Group
  • Pfizer
  • GlaxoSmithKline
  • AbbVie
  • Samsung BioLogics
  • Rentschler Biotechnologie
  • ProBioGen
  • Novo Medi Sciences
  • JRS Pharma
  • Galentic Pharma
  • FUJIFILM Diosynth Biotechnologies
  • Boehringer Ingelheim
  • AGC Biologics

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Biopharmaceuticals Contract Manufacturing Service by Type
  3. 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
  4. 2.2.2 Packaging
  5. 2.2.3 Process Development
  6. 2.2.4 Manufacturing
  7. 2.3 Biopharmaceuticals Contract Manufacturing Service by Application
  8. 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  9. 2.3.2 Vaccines
  10. 2.3.3 Peptides and Protein
  11. 2.3.4 Biosimilars
  12. 2.3.5 Antibodies
  13. 2.3.6 Others
  14. 2.4 Assumptions and Limitations
3 Biopharmaceuticals Contract Manufacturing Service Breakdown Data by Type
  1. 3.1 Global Biopharmaceuticals Contract Manufacturing Service Historic Market Size by Type (2021-2026)
  2. 3.2 Global Biopharmaceuticals Contract Manufacturing Service Forecasted Market Size by Type (2027-2032)
4 Biopharmaceuticals Contract Manufacturing Service Breakdown Data by Application
  1. 4.1 Global Biopharmaceuticals Contract Manufacturing Service Historic Market Size by Application (2021-2026)
  2. 4.2 Global Biopharmaceuticals Contract Manufacturing Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
  1. 5.1 Global Biopharmaceuticals Contract Manufacturing Service Market Perspective (2021-2032)
  2. 5.2 Global Biopharmaceuticals Contract Manufacturing Service Growth Trends by Region
  3. 5.2.1 Global Biopharmaceuticals Contract Manufacturing Service Market Size by Region: 2021 VS 2025 VS 2032
  4. 5.2.2 Biopharmaceuticals Contract Manufacturing Service Historic Market Size by Region (2021-2026)
  5. 5.2.3 Biopharmaceuticals Contract Manufacturing Service Forecasted Market Size by Region (2027-2032)
  6. 5.3 Biopharmaceuticals Contract Manufacturing Service Market Dynamics
  7. 5.3.1 Biopharmaceuticals Contract Manufacturing Service Industry Trends
  8. 5.3.2 Biopharmaceuticals Contract Manufacturing Service Market Drivers
  9. 5.3.3 Biopharmaceuticals Contract Manufacturing Service Market Challenges
  10. 5.3.4 Biopharmaceuticals Contract Manufacturing Service Market Restraints
6 Market Competitive Landscape by Players
  1. 6.1 Global Top Biopharmaceuticals Contract Manufacturing Service Players by Revenue
  2. 6.1.1 Global Top Biopharmaceuticals Contract Manufacturing Service Players by Revenue (2021-2026)
  3. 6.1.2 Global Biopharmaceuticals Contract Manufacturing Service Revenue Market Share by Players (2021-2026)
  4. 6.2 Global Biopharmaceuticals Contract Manufacturing Service Industry Players Ranking, 2023 VS 2024 VS 2025
  5. 6.3 Global Key Players of Biopharmaceuticals Contract Manufacturing Service Head Office and Area Served
  6. 6.4 Global Biopharmaceuticals Contract Manufacturing Service Players, Product Type & Application
  7. 6.5 Global Biopharmaceuticals Contract Manufacturing Service Manufacturers Established Date
  8. 6.6 Global Biopharmaceuticals Contract Manufacturing Service Market CR5 and HHI
  9. 6.7 Global Players Mergers & Acquisition
7 North America
  1. 7.1 North America Biopharmaceuticals Contract Manufacturing Service Market Size (2021-2032)
  2. 7.2 North America Biopharmaceuticals Contract Manufacturing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 7.3 North America Biopharmaceuticals Contract Manufacturing Service Market Size by Country (2021-2026)
  4. 7.4 North America Biopharmaceuticals Contract Manufacturing Service Market Size by Country (2027-2032)
  5. 7.5 United States
  6. 7.5 United States
  7. 7.6 Canada
  8. 7.7 Mexico
8 Europe
  1. 8.1 Europe Biopharmaceuticals Contract Manufacturing Service Market Size (2021-2032)
  2. 8.2 Europe Biopharmaceuticals Contract Manufacturing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 8.3 Europe Biopharmaceuticals Contract Manufacturing Service Market Size by Country (2021-2026)
  4. 8.4 Europe Biopharmaceuticals Contract Manufacturing Service Market Size by Country (2027-2032)
  5. 8.5 Germany
  6. 8.6 France
  7. 8.7 U.K.
  8. 8.8 Italy
  9. 8.9 Spain
  10. 8.10 Russia
  11. 8.11 Netherlands
  12. 8.12 Nordic Countries
9 Asia-Pacific
  1. 9.1 Asia-Pacific Biopharmaceuticals Contract Manufacturing Service Market Size (2021-2032)
  2. 9.2 Asia-Pacific Biopharmaceuticals Contract Manufacturing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 9.3 Asia-Pacific Biopharmaceuticals Contract Manufacturing Service Market Size by Country (2021-2026)
  4. 9.4 Asia-Pacific Biopharmaceuticals Contract Manufacturing Service Market Size by Country (2027-2032)
  5. 9.5 China
  6. 9.6 Japan
  7. 9.7 South Korea
  8. 9.8 India
  9. 9.9 Australia
  10. 9.10 China Taiwan
  11. 9.11 Southeast Asia
10 South America
  1. 10.1 South America Biopharmaceuticals Contract Manufacturing Service Market Size (2021-2032)
  2. 10.2 South America Biopharmaceuticals Contract Manufacturing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 10.3 South America Biopharmaceuticals Contract Manufacturing Service Market Size by Country (2021-2026)
  4. 10.4 South America Biopharmaceuticals Contract Manufacturing Service Market Size by Country (2027-2032)
  5. 10.5 Brazil
  6. 10.6 Argentina
  7. 10.7 Chile
  8. 10.8 Colombia
  9. 10.9 Peru
11 Middle East & Africa
  1. 11.1 Middle East & Africa Biopharmaceuticals Contract Manufacturing Service Market Size (2021-2032)
  2. 11.2 Middle East & Africa Biopharmaceuticals Contract Manufacturing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 11.3 Middle East & Africa Biopharmaceuticals Contract Manufacturing Service Market Size by Country (2021-2026)
  4. 11.4 Middle East & Africa Biopharmaceuticals Contract Manufacturing Service Market Size by Country (2027-2032)
  5. 11.5 Saudi Arabia
  6. 11.6 Israel
  7. 11.7 United Arab Emirates
  8. 11.8 Turkey
  9. 11.9 Iran
  10. 11.10 Egypt
12 Players Profiled
  1. 12.1 WuXi Biologics
  2. 12.1.1 WuXi Biologics Company Information
  3. 12.1.2 WuXi Biologics Business Overview
  4. 12.1.3 WuXi Biologics Revenue in Biopharmaceuticals Contract Manufacturing Service Business (2021-2026)
  5. 12.1.4 WuXi Biologics Biopharmaceuticals Contract Manufacturing Service Product Portfolio
  6. 12.1.5 WuXi Biologics Recent Developments
  7. 12.2 Takeda
  8. 12.2.1 Takeda Company Information
  9. 12.2.2 Takeda Business Overview
  10. 12.2.3 Takeda Revenue in Biopharmaceuticals Contract Manufacturing Service Business (2021-2026)
  11. 12.2.4 Takeda Biopharmaceuticals Contract Manufacturing Service Product Portfolio
  12. 12.2.5 Takeda Recent Developments
  13. 12.3 Sanofi
  14. 12.3.1 Sanofi Company Information
  15. 12.3.2 Sanofi Business Overview
  16. 12.3.3 Sanofi Revenue in Biopharmaceuticals Contract Manufacturing Service Business (2021-2026)
  17. 12.3.4 Sanofi Biopharmaceuticals Contract Manufacturing Service Product Portfolio
  18. 12.3.5 Sanofi Recent Developments
  19. 12.4 Johnson & Johnson
  20. 12.4.1 Johnson & Johnson Company Information
  21. 12.4.2 Johnson & Johnson Business Overview
  22. 12.4.3 Johnson & Johnson Revenue in Biopharmaceuticals Contract Manufacturing Service Business (2021-2026)
  23. 12.4.4 Johnson & Johnson Biopharmaceuticals Contract Manufacturing Service Product Portfolio
  24. 12.4.5 Johnson & Johnson Recent Developments
  25. 12.5 Merck
  26. 12.5.1 Merck Company Information
  27. 12.5.2 Merck Business Overview
  28. 12.5.3 Merck Revenue in Biopharmaceuticals Contract Manufacturing Service Business (2021-2026)
  29. 12.5.4 Merck Biopharmaceuticals Contract Manufacturing Service Product Portfolio
  30. 12.5.5 Merck Recent Developments
  31. 12.6 Roche
  32. 12.6.1 Roche Company Information
  33. 12.6.2 Roche Business Overview
  34. 12.6.3 Roche Revenue in Biopharmaceuticals Contract Manufacturing Service Business (2021-2026)
  35. 12.6.4 Roche Biopharmaceuticals Contract Manufacturing Service Product Portfolio
  36. 12.6.5 Roche Recent Developments
  37. 12.7 Lonza Group
  38. 12.7.1 Lonza Group Company Information
  39. 12.7.2 Lonza Group Business Overview
  40. 12.7.3 Lonza Group Revenue in Biopharmaceuticals Contract Manufacturing Service Business (2021-2026)
  41. 12.7.4 Lonza Group Biopharmaceuticals Contract Manufacturing Service Product Portfolio
  42. 12.7.5 Lonza Group Recent Developments
  43. 12.8 Pfizer
  44. 12.8.1 Pfizer Company Information
  45. 12.8.2 Pfizer Business Overview
  46. 12.8.3 Pfizer Revenue in Biopharmaceuticals Contract Manufacturing Service Business (2021-2026)
  47. 12.8.4 Pfizer Biopharmaceuticals Contract Manufacturing Service Product Portfolio
  48. 12.8.5 Pfizer Recent Developments
  49. 12.9 GlaxoSmithKline
  50. 12.9.1 GlaxoSmithKline Company Information
  51. 12.9.2 GlaxoSmithKline Business Overview
  52. 12.9.3 GlaxoSmithKline Revenue in Biopharmaceuticals Contract Manufacturing Service Business (2021-2026)
  53. 12.9.4 GlaxoSmithKline Biopharmaceuticals Contract Manufacturing Service Product Portfolio
  54. 12.9.5 GlaxoSmithKline Recent Developments
  55. 12.10 AbbVie
  56. 12.10.1 AbbVie Company Information
  57. 12.10.2 AbbVie Business Overview
  58. 12.10.3 AbbVie Revenue in Biopharmaceuticals Contract Manufacturing Service Business (2021-2026)
  59. 12.10.4 AbbVie Biopharmaceuticals Contract Manufacturing Service Product Portfolio
  60. 12.10.5 AbbVie Recent Developments
  61. 12.11 Samsung BioLogics
  62. 12.11.1 Samsung BioLogics Company Information
  63. 12.11.2 Samsung BioLogics Business Overview
  64. 12.11.3 Samsung BioLogics Revenue in Biopharmaceuticals Contract Manufacturing Service Business (2021-2026)
  65. 12.11.4 Samsung BioLogics Biopharmaceuticals Contract Manufacturing Service Product Portfolio
  66. 12.11.5 Samsung BioLogics Recent Developments
  67. 12.12 Rentschler Biotechnologie
  68. 12.12.1 Rentschler Biotechnologie Company Information
  69. 12.12.2 Rentschler Biotechnologie Business Overview
  70. 12.12.3 Rentschler Biotechnologie Revenue in Biopharmaceuticals Contract Manufacturing Service Business (2021-2026)
  71. 12.12.4 Rentschler Biotechnologie Biopharmaceuticals Contract Manufacturing Service Product Portfolio
  72. 12.12.5 Rentschler Biotechnologie Recent Developments
  73. 12.13 ProBioGen
  74. 12.13.1 ProBioGen Company Information
  75. 12.13.2 ProBioGen Business Overview
  76. 12.13.3 ProBioGen Revenue in Biopharmaceuticals Contract Manufacturing Service Business (2021-2026)
  77. 12.13.4 ProBioGen Biopharmaceuticals Contract Manufacturing Service Product Portfolio
  78. 12.13.5 ProBioGen Recent Developments
  79. 12.14 Novo Medi Sciences
  80. 12.14.1 Novo Medi Sciences Company Information
  81. 12.14.2 Novo Medi Sciences Business Overview
  82. 12.14.3 Novo Medi Sciences Revenue in Biopharmaceuticals Contract Manufacturing Service Business (2021-2026)
  83. 12.14.4 Novo Medi Sciences Biopharmaceuticals Contract Manufacturing Service Product Portfolio
  84. 12.14.5 Novo Medi Sciences Recent Developments
  85. 12.15 JRS Pharma
  86. 12.15.1 JRS Pharma Company Information
  87. 12.15.2 JRS Pharma Business Overview
  88. 12.15.3 JRS Pharma Revenue in Biopharmaceuticals Contract Manufacturing Service Business (2021-2026)
  89. 12.15.4 JRS Pharma Biopharmaceuticals Contract Manufacturing Service Product Portfolio
  90. 12.15.5 JRS Pharma Recent Developments
  91. 12.16 Galentic Pharma
  92. 12.16.1 Galentic Pharma Company Information
  93. 12.16.2 Galentic Pharma Business Overview
  94. 12.16.3 Galentic Pharma Revenue in Biopharmaceuticals Contract Manufacturing Service Business (2021-2026)
  95. 12.16.4 Galentic Pharma Biopharmaceuticals Contract Manufacturing Service Product Portfolio
  96. 12.16.5 Galentic Pharma Recent Developments
  97. 12.17 FUJIFILM Diosynth Biotechnologies
  98. 12.17.1 FUJIFILM Diosynth Biotechnologies Company Information
  99. 12.17.2 FUJIFILM Diosynth Biotechnologies Business Overview
  100. 12.17.3 FUJIFILM Diosynth Biotechnologies Revenue in Biopharmaceuticals Contract Manufacturing Service Business (2021-2026)
  101. 12.17.4 FUJIFILM Diosynth Biotechnologies Biopharmaceuticals Contract Manufacturing Service Product Portfolio
  102. 12.17.5 FUJIFILM Diosynth Biotechnologies Recent Developments
  103. 12.18 Boehringer Ingelheim
  104. 12.18.1 Boehringer Ingelheim Company Information
  105. 12.18.2 Boehringer Ingelheim Business Overview
  106. 12.18.3 Boehringer Ingelheim Revenue in Biopharmaceuticals Contract Manufacturing Service Business (2021-2026)
  107. 12.18.4 Boehringer Ingelheim Biopharmaceuticals Contract Manufacturing Service Product Portfolio
  108. 12.18.5 Boehringer Ingelheim Recent Developments
  109. 12.19 AGC Biologics
  110. 12.19.1 AGC Biologics Company Information
  111. 12.19.2 AGC Biologics Business Overview
  112. 12.19.3 AGC Biologics Revenue in Biopharmaceuticals Contract Manufacturing Service Business (2021-2026)
  113. 12.19.4 AGC Biologics Biopharmaceuticals Contract Manufacturing Service Product Portfolio
  114. 12.19.5 AGC Biologics Recent Developments
13 Report Conclusion
    14 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst